|
|||||
|
|
Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development. |
|
| Authors: | John W Park Robert S Kerbel Gary J Kelloff J Carl Barrett Bruce A Chabner David R Parkinson Jonathan Peck Raymond W Ruddon Caroline C Sigman Dennis J Slamon |
| Affiliation: | University of California, San Francisco Cancer Center, San Francisco, California 94115-1710, USA. jpark@cc.ucsf.edu |
| Abstract: | |
| Keywords: | |